XORTX Therapeutics Inc. XRTX
1.69
(0.03)
(1.74%)
as of 25 Sep
- Market cap
- $3.2M
- P/E
- 0.0×
Follow XRTX
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
3.59 | 0.86 | 2.11 | 1.62 |
+8 more quarters Free account |
Net Debt/EBITDA |
0.59 | 0.31 | 1.32 | 1.74 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.93 | 0.62 | 1.19 | 0.97 | |
Capex/Depreciation |
(7.80) | (0.15) | (0.84) | (0.19) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.41 | 0.09 | 0.07 | 0.07 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(2.11) | (0.36) | (0.77) | (0.65) | |
Cash per Share |
0.61 | 0.18 | 0.91 | 1.23 | |
Shareholders Equity per Share |
3.40 | 0.92 | 2.20 | 2.03 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.40 | 0.92 | 2.20 | 2.03 | |
Free Cash Flow |
(3.41) | (0.51) | (0.73) | (0.64) | |
Working Capital |
1.76 | (0.12) | 0.66 | 0.52 | |
Capital Expenditures |
(0.14) | 0.00 | (0.02) | (0.01) | |
Net Current Asset Value |
1.76 | (0.12) | 0.66 | 0.52 | |
| Other line items | |||||
Quick Ratio |
1.59 | 0.37 | 1.58 | 1.45 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(2.02) | (0.36) | (0.74) | (0.65) | |
Capex per Share |
(0.09) | 0.00 | (0.03) | (0.01) | |
Average Receivables |
0.05 | 0.04 | 0.05 | 0.02 | |
Average Payables |
0.57 | 0.63 | 0.35 | 0.50 | |
Average Assets |
4.46 | 2.82 | 3.39 | 3.33 | |
Average Common Equity |
3.77 | 2.01 | 2.71 | 2.05 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates